Dr. Rubnitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 1991 - 1994
- Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1988 - 1991
- University of California San Diego School of MedicineClass of 1988
Certifications & Licensure
- CA State Medical License 1989 - Present
- TN State Medical License 1995 - 2026
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia Start of enrollment: 2002 Aug 01
- Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia Start of enrollment: 2002 Mar 01
- Natural Killer (NK) Cell Transplantation for AML Start of enrollment: 2005 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 152 citationsComparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid LeukemiaHiroto Inaba, Elaine Coustan-Smith, Xueyuan Cao, Stanley Pounds, Sheila A. Shurtleff
Journal of Clinical Oncology. 2012-10-10 - 9 citationsCPX-351 Induces Remission in Newly Diagnosed Pediatric Secondary Myeloid Malignancies.Yixin Hu, Kenneth J. Caldwell, Mihaela Onciu, Sara M. Federico, Marta Salek
Blood Advances. 2021-10-28 - 58 citationsClinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospec...Kim Klein, Gertjan J.L. Kaspers, Christine J. Harrison, H. Berna Beverloo, Ardine Reedijk
Journal of Clinical Oncology. 2015-11-16
Abstracts/Posters
- Venetoclax in Combination with High-Dose Chemotherapy Is Active and Well-Tolerated in Children with Relapsed or Refractory Acute Myeloid LeukemiaClinically Relevant Ab...Jeffrey Rubnitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaJeffrey Rubnitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A 5-Gene Ara-C, Daunorubicin and Etoposide (ADE) Drug Response Score As a Prognostic Tool to Predict AML Treatment OutcomeJeffrey Rubnitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- Drug Offers Promising Approach to Improve Outcome for Children with High-Risk LeukemiaFebruary 10th, 2016
- Drug Offers Promising Approach to Improve Outcome for Children with High-Risk LeukemiaFebruary 10th, 2016
- Drug Offers Promising Approach to Improve Outcome for Children with High-Risk LeukemiaFebruary 10th, 2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: